Marco Binder
Marco Binder
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
E Meylan, J Curran, K Hofmann, D Moradpour, M Binder, ...
Nature 437 (7062), 1167-1172, 2005
Viral immune modulators perturb the human molecular network by common and unique strategies
A Pichlmair, K Kandasamy, G Alvisi, O Mulhern, R Sacco, M Habjan, ...
Nature 487 (7408), 486-490, 2012
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, ...
Nature biotechnology 40 (3), 319-324, 2022
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
CJ Neufeldt, B Cerikan, M Cortese, J Frankish, JY Lee, ...
Communications biology 5 (1), 45, 2022
Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
R Thimme, M Binder, R Bartenschlager
FEMS microbiology reviews 36 (3), 663-683, 2012
Ubiquitin-dependent and-independent roles of E3 ligase RIPLET in innate immunity
C Cadena, S Ahmad, A Xavier, J Willemsen, S Park, JW Park, SW Oh, ...
Cell 177 (5), 1187-1200. e16, 2019
Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus
S Bender, A Reuter, F Eberle, E Einhorn, M Binder, R Bartenschlager
PLoS pathogens 11 (11), e1005264, 2015
Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19
S Trump, S Lukassen, MS Anker, RL Chua, J Liebig, L Thürmann, ...
Nature biotechnology 39 (6), 705-716, 2021
Role of annexin A2 in the production of infectious hepatitis C virus particles
P Backes, D Quinkert, S Reiss, M Binder, M Zayas, U Rescher, V Gerke, ...
Journal of virology 84 (11), 5775-5789, 2010
Identification of type I and type II interferon‐induced effectors controlling hepatitis C virus replication
P Metz, E Dazert, A Ruggieri, J Mazur, L Kaderali, A Kaul, U Zeuge, ...
Hepatology 56 (6), 2082-2093, 2012
HBV bypasses the innate immune response and does not protect HCV from antiviral activity of interferon
P Mutz, P Metz, FA Lempp, S Bender, B Qu, K Schöneweis, S Seitz, T Tu, ...
Gastroenterology 154 (6), 1791-1804. e22, 2018
Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I)
M Binder, F Eberle, S Seitz, N Mücke, CM Hüber, N Kiani, L Kaderali, ...
Journal of Biological Chemistry 286 (31), 27278-27287, 2011
Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy
M Binder, G Kochs, R Bartenschlager, V Lohmann
Hepatology 46 (5), 1365-1374, 2007
Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras
M Binder, D Quinkert, O Bochkarova, R Klein, N Kezmic, ...
Journal of virology 81 (10), 5270-5283, 2007
Bacterial RNA is recognized by different sets of immunoreceptors
F Eberle, M Sirin, M Binder, AH Dalpke
European journal of immunology 39 (9), 2537-2547, 2009
Replication vesicles are load-and choke-points in the hepatitis C virus lifecycle
M Binder, N Sulaimanov, D Clausznitzer, M Schulze, CM Hüber, SM Lenz, ...
PLoS pathogens 9 (8), e1003561, 2013
RIPLET, and not TRIM25, is required for endogenous RIG‐I‐dependent antiviral responses
TJ Hayman, AC Hsu, TB Kolesnik, LF Dagley, J Willemsen, MD Tate, ...
Immunology and cell biology 97 (9), 840-852, 2019
Phosphorylation of TRIM28 enhances the expression of IFN-β and proinflammatory cytokines during HPAIV infection of human lung epithelial cells
T Krischuns, F Günl, L Henschel, M Binder, J Willemsen, S Schloer, ...
Frontiers in immunology 9, 2229, 2018
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines
K Börner, D Niopek, G Cotugno, M Kaldenbach, T Pankert, J Willemsen, ...
Nucleic acids research 41 (21), e199-e199, 2013
Secretion of hepatitis C virus replication intermediates reduces activation of toll-like receptor 3 in hepatocytes
O Grünvogel, O Colasanti, JY Lee, V Klöss, S Belouzard, A Reustle, ...
Gastroenterology 154 (8), 2237-2251. e16, 2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20